For Medical Institutions
CureApp Smoking Cessation
Co-developed with the Keio University Respiratory Internal Medicine Classroom Patent Acquired on March 31, 2017.
Why CureApp Deals with Smoking Cessation Treatment
Smoking has a high mortality rate, and support for treating the psychological dependence of addiction is lack, therefore reduces the success of the treatment methods. We hope to change this situation using technology.
A study entitled “Adult Mortality Attributable to Preventable Risk Factors for Noncommunicable Diseases and Injuries in Japan
Nicotine Addiction Treatment
There are two aspects of nicotine dependence: physical dependence and psychological dependence. Although smoking cessation aids have an impact on the physical aspects of nicotine dependence, currently, there is no empirically backed evidence for the treatment of the psychological aspect of nicotine addiction. For this reason a treatment that can stop the psychological aspect of nicotine addiction is required.
Portable Instrument for Measuring CO Levels in Breath Integrated Treatment Application
Measurement of CO concentration levels in breath as an objective indicator of the success or failure of smoking cessation treatment. Such measurements are important and stipulations state that they should be made regularly. In fact, the smoking cessation rate is confirmed only by "self-assessments", "self-reports" and the "exhaled CO concentration values". There is also evidence and theories that indicate there is a divergence between the confirmed quit rate, and the actual quit rate of smoking cessation. The CO concentration measurement is useful for accurately confirming the success or failure of a patient’s success at quitting smoking. Furthermore, conventional exhaled CO concentration measuring instruments are not available for individual patients due to their size and cost. This makes it necessary for patients to visit medical institutions such as hospital facilities with the required equipment to obtain measurements.
At our company, we have taken the above diagnostic issues into consideration. In order to make it possible to measure the exhaled breath CO concentration of patients on a daily basis and improve the accuracy of the course of treatment even in the case of remote medical care, we propose a solution integrated with the IoT device X therapy application with the following three features. (1) Miniaturization and portability, (2) low cost and (3) visualization of measurement results at frequent intervals.
Nicotine addiction management fee information facility standards (4) external link.
For Medical Institutions
Co-developed with the University of Tokyo School of Medicine Affiliated Hospital
Why CureApp Deals with Liver Treatment
Although the reason is still not fully known to the world, fatty liver disease can progress to cirrhosis of the liver or liver cancer. This leads to a situation with a high risk of death. Despite this, the treatment of fatty liver disease has yet to be well established. CureApp aims to create a new treatment method to prevent such serious problems using the power of technology.
Progression from fatty liver disease to liver cirrhosis greatly increases the likelihood of a patient developing liver cancer. If diagnosed with liver cirrhosis, it is impossible for the liver to return to a normal state, thus it necessary to provide appropriate treatment at the fatty liver stage.